SVANOVIR®F.hepatica-Ab on the E/S protein and detects antibodies to Fasciola hepatica (F. hepatica) in dairy and beef cattle. The assay has been validated using naturally infected populations and is the first test enabling the identification of herds and individuals that exceed an acceptable level of infection.
YOUR CHALLENGE is a subclinical disease resulting in production loss.
Cattle take up infectious stages of F. hepatica while grazing in wet pastures. Flukes affect the liver but fasciolosis is primarily subclinical with no obvious clinical signs. However, production loss increases in correlation to the numbers of Flukes affecting the liver. In Western Europe herd-level prevalence varies between 30-80%.
YOUR GOAL is to identify herds with F. hepatica induced production losses.
F. hepatica cannot be eradicated, but it is possible to control the impact of infection on production output. Monitoring and maintaining herd infection at an acceptable level, where there is no loss of production, is a new way to manage fasciolosis. In order to ensure rational and selective use of anthelminthic treatment, it is essential that the effectiveness of the control strategies is monitored.
First test for economic diagnosis of F. hepatica.
Enables monitoring of the effectiveness of control strategies.
Thoroughly validated on naturally infected populations.
High sample throughput
- effective screening of herds and numerous individuals
Triple functionality
- milk, serum and meat juice samples can be run in the same assay.
Effective handling - ready-to-use conjugate and flexible incubation times (short overnight).